Hisamitsu Pharmaceutical Co., Inc.

58
Hold
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3784600003
JPY
4,145.00
-75 (-1.78%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Feb'25
Feb'24
Feb'23
Feb'22
Feb'21
Feb'20
No of Months
12
12
12
12
12
12
Operating Income
1,56,006.00
1,41,706.00
1,28,330.00
1,20,193.00
1,14,510.00
1,40,992.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,56,006.00
1,41,706.00
1,28,330.00
1,20,193.00
1,14,510.00
1,40,992.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
9,763.00
9,486.00
9,826.00
10,164.00
Operating Expenses
23.00
18.00
15.00
20.00
10.00
19.00
General and Administration Expenses
61,397.00
57,189.00
51,314.00
50,117.00
47,735.00
54,371.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,37,110.00
1,28,538.00
1,16,729.00
1,10,856.00
1,03,838.00
1,18,263.00
Operating Profit (PBDIT) excl Other Income
18,896.00
13,168.00
11,601.00
9,337.00
10,672.00
22,729.00
Other Income
10,158.00
6,928.00
4,987.00
3,716.00
1,777.00
2,966.00
Operating Profit (PBDIT)
35,389.00
25,268.00
21,540.00
17,374.00
16,528.00
29,946.00
Interest
23.00
18.00
15.00
20.00
10.00
19.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
6,335.00
5,172.00
4,952.00
4,321.00
4,079.00
4,251.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
28,687.00
19,186.00
16,113.00
12,956.00
12,197.00
26,155.00
Provision for Tax
6,385.00
4,754.00
3,987.00
3,093.00
2,764.00
7,244.00
Profit After Tax
21,758.00
13,970.00
11,743.00
9,658.00
9,251.00
18,694.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
295.15
181.41
147.87
118.84
113.10
227.30
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Feb 2025 is 10.09% vs 10.42% in Feb 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Feb 2025 is 43.50% vs 13.51% in Feb 2024

stock-summary

Interest

YoY Growth in year ended Feb 2025 is 27.78% vs 20.00% in Feb 2024

stock-summary

Profit After Tax

YoY Growth in year ended Feb 2025 is 55.75% vs 18.96% in Feb 2024

Compare Profit and Loss Results of Hisamitsu Pharmaceutical Co., Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
1,56,006.00
3,00,004.00
-1,43,998.00
-48.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,56,006.00
3,00,004.00
-1,43,998.00
-48.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
23.00
2,716.00
-2,693.00
-99.15%
General and Administration Expenses
61,397.00
87,967.00
-26,570.00
-30.20%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,37,110.00
2,49,859.00
-1,12,749.00
-45.13%
Operating Profit (PBDIT) excl Other Income
18,896.00
50,145.00
-31,249.00
-62.32%
Other Income
10,158.00
737.00
9,421.00
1,278.29%
Operating Profit (PBDIT)
35,389.00
68,830.00
-33,441.00
-48.58%
Interest
23.00
2,716.00
-2,693.00
-99.15%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
6,335.00
17,948.00
-11,613.00
-64.70%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
28,687.00
48,166.00
-19,479.00
-40.44%
Provision for Tax
6,385.00
11,628.00
-5,243.00
-45.09%
Profit After Tax
21,758.00
36,247.00
-14,489.00
-39.97%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
295.1518
103.6792
191.47
184.68%
Profit And Loss - Net Sales
Net Sales 1,56,006.00 Million
in Feb 2025

Figures in Million
stock-summary

YoY Growth in year ended Feb 2025 is 10.09% vs 10.42% in Feb 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18,896.00 Million
in Feb 2025

Figures in Million
stock-summary

YoY Growth in year ended Feb 2025 is 43.50% vs 13.51% in Feb 2024

Profit And Loss - Interest
Interest 23.00 Million
in Feb 2025

Figures in Million
stock-summary

YoY Growth in year ended Feb 2025 is 27.78% vs 20.00% in Feb 2024

Profit And Loss - Profit After Tax
Profit After Tax 21,758.00 Million
in Feb 2025

Figures in Million
stock-summary

YoY Growth in year ended Feb 2025 is 55.75% vs 18.96% in Feb 2024